@tomhemmingk
www.thelancet.com Empowering regulatory science for medical devices in Europe From clinical and ethical perspectives, the need for scientific evidence establishing safety and efficacy of high-risk therapeutic medical devices, and for transparency of that evidence, is similar... 🎉 We're proud to announce that our journal has achieved an Impact Factor of 40.1, now the highest in the field.
Thank you to our editors, editorial board members, reviewers, authors, and publishing colleagues for making this possible. 👏View quoted post on X
www.medrxiv.org Resolving inflammatory bowel disease risk variants to genes and cell types Inflammatory bowel diseases (IBD), principally Crohn’s disease (CD) and ulcerative colitis (UC), are common chronic disorders involving inflammation and often progressive tissue damage. Genome-wide... 
